Pharsight

UCB BIOPHARMA PATENTS FACING OPPOSITIONS

Top patents of UCB BIOPHARMA facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2515887B1 Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine NA 2
EP2922533B1 14 Jun, 2017 Multi-day patch for the transdermal administration of rotigotine Nov, 2033 2
EP3311168B1 10 May, 2023 Novel tnf structure for use in therapy NA 1